BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
|
Back to Search Results |
|
Model Number G124 |
Device Problems
Premature Discharge of Battery (1057); Failure to Capture (1081); Over-Sensing (1438); Battery Problem (2885); High Capture Threshold (3266)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/19/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d), implanted with another manufacturer's left ventricular (lv) lead, exhibited atrial fibrillation (af) oversensing and loss of capture (loc) up to 6v@1ms.The field representative noted that lv thresholds have been chronically high.Technical services (ts) reviewed possible causes, and remote monitoring data revealed that the observed af was new as of (b)(6) 2023.It was also noted that the lv lead was likely in a basal/anterior position, which likely contributed to the atrial fibrillation (af) oversensing.Technical services (ts) reviewed troubleshooting options.The lv lead was reprogrammed to a different vector/output and lv sensing was turned off.This crt-d system remains in service.No adverse patient effects were reported.
|
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d), implanted with another manufacturer's left ventricular (lv) lead, exhibited atrial fibrillation (af) oversensing and loss of capture (loc) up to 6v@1ms.The field representative noted that lv thresholds have been chronically high.Technical services (ts) reviewed possible causes, and remote monitoring data revealed that the observed af was new as of may 2023.It was also noted that the lv lead was likely in a basal/anterior position, which likely contributed to the atrial fibrillation (af) oversensing.Technical services (ts) reviewed troubleshooting options.The lv lead was reprogrammed to a different vector/output and lv sensing was turned off.This crt-d system remains in service.No adverse patient effects were reported.Additional information received reported that the battery of this cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely, and a request was made to have data from this device analyzed.Data analysis indicated the battery appeared to be depleting normally, and the elevated power consumption was due to sensing of high atrial rates.This crt-d remains in service.No adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|